30 Day Psychedelic Pharmacology Podcast - Day 29 Future Directions

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the future of psychedelic therapy, focusing on personalized medicine and innovative delivery methods. Key topics include:- The role of AI in drug discovery and receptor modeling- New delivery methods like transdermal patches and nasal sprays for controlled dosing- The importance of set and setting in therapeutic outcomes- The interaction between MDMA and various serotonin receptors (5HT2A, 5HT2C, and 5HT2B)- The potential of personalized medicine in psychedelic therapyThe discussion also addresses ethical considerations and the current legal challenges facing psychedelic research.

NOW PLAYING

0:00 15:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 15 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!